<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32412778</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1522-1539</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>319</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jul</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of physiology. Heart and circulatory physiology</Title>
          <ISOAbbreviation>Am J Physiol Heart Circ Physiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chemogenetic activation of intracardiac cholinergic neurons improves cardiac function in pressure overload-induced heart failure.</ArticleTitle>
        <Pagination>
          <StartPage>H3</StartPage>
          <EndPage>H12</EndPage>
          <MedlinePgn>H3-H12</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpheart.00150.2020</ELocationID>
        <Abstract>
          <AbstractText>Heart failure (HF) is characterized by autonomic imbalance with sympathetic hyperactivity and loss of parasympathetic tone. Intracardiac ganglia (ICG) neurons represent the final common pathway for vagal innervation of the heart and strongly regulate cardiac functions. This study tests whether ICG cholinergic neuron activation mitigates the progression of cardiac dysfunction and reduces mortality that occurs in HF. HF was induced by transaortic constriction (TAC) in male transgenic Long-Evans rats expressing Cre recombinase within choline acetyltransferase (ChAT) neurons. ChAT neurons were selectively activated by expression and activation of excitatory designer receptors exclusively activated by designer receptors (DREADDs) by clozapine-<i>N</i>-oxide (TAC + treatment and sham-treated groups). Control animals expressed DREADDs but received saline (sham and TAC groups). A separate set of animals were telemetry instrumented to record blood pressure (BP) and heart rate (HR). Acute activation of ICG neurons resulted in robust reductions in BP (∼20 mmHg) and HR (∼100 beats/min). All groups of animals were subjected to weekly echocardiography and treadmill stress tests from 3 to 6 wk post-TAC/sham surgery. Activation of ICG cholinergic neurons reduced the left ventricular systolic dysfunction (reductions in ejection fraction, fractional shortening, stroke volume, and cardiac output) and cardiac autonomic dysfunction [reduced HR recovery (HRR) post peak effort] observed in TAC animals. Additionally, activation of ICG ChAT neurons reduced mortality by 30% compared with untreated TAC animals. These data suggest that ICG cholinergic neuron activation reduces cardiac dysfunction and improves survival in HF, indicating that ICG neuron activation could be a novel target for treating HF.<b>NEW &amp; NOTEWORTHY</b> Intracardiac ganglia form the final common pathway for the parasympathetic innervation of the heart. This study has used a novel chemogenetic approach within transgenic ChAT-Cre rats [expressing only Cre-recombinase in choline acetyl transferase (ChAT) neurons] to selectively increase intracardiac cholinergic parasympathetic activity to the heart in a pressure overload-induced heart failure model. The findings from this study confirm that selective activation of intracardiac cholinergic neurons lessens cardiac dysfunction and mortality seen in heart failure, identifying a novel downstream cardiac-selective target for increasing cardioprotective parasympathetic activity in heart failure.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dyavanapalli</LastName>
            <ForeName>Jhansi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Physiology, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hora</LastName>
            <ForeName>Aloysius James</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Physiology, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Escobar</LastName>
            <ForeName>Joan B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Physiology, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schloen</LastName>
            <ForeName>John</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-9642-3539</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dwyer</LastName>
            <ForeName>Mary Kate</ForeName>
            <Initials>MK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodriguez</LastName>
            <ForeName>Jeannette</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0001-7791-5266</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spurney</LastName>
            <ForeName>Christopher F</ForeName>
            <Initials>CF</Initials>
            <AffiliationInfo>
              <Affiliation>Children's National Heart Institute, Center for Genetic Medicine Research, Children's National Health System, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kay</LastName>
            <ForeName>Matthew W</ForeName>
            <Initials>MW</Initials>
            <Identifier Source="ORCID">0000-0003-2756-5055</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Engineering, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mendelowitz</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Physiology, George Washington University, Washington, District of Columbia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 HL133862</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 HL146169</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>HL146169</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>HL133862</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>05</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Am J Physiol Heart Circ Physiol</MedlineTA>
        <NlmUniqueID>100901228</NlmUniqueID>
        <ISSNLinking>0363-6135</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 2.3.1.6</RegistryNumber>
          <NameOfSubstance UI="D002795">Choline O-Acetyltransferase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>J60AR2IKIC</RegistryNumber>
          <NameOfSubstance UI="D003024">Clozapine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>MZA8BK588J</RegistryNumber>
          <NameOfSubstance UI="C079149">clozapine N-oxide</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002795" MajorTopicYN="N">Choline O-Acetyltransferase</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059329" MajorTopicYN="N">Cholinergic Neurons</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003024" MajorTopicYN="N">Clozapine</DescriptorName>
          <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName>
          <QualifierName UI="Q000294" MajorTopicYN="Y">innervation</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020318" MajorTopicYN="N">Rats, Long-Evans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016276" MajorTopicYN="Y">Ventricular Function</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014694" MajorTopicYN="N">Ventricular Outflow Obstruction</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">DREADDs</Keyword>
        <Keyword MajorTopicYN="Y">acetylcholine</Keyword>
        <Keyword MajorTopicYN="Y">autonomic</Keyword>
        <Keyword MajorTopicYN="Y">heart failure</Keyword>
        <Keyword MajorTopicYN="Y">parasympathetic</Keyword>
      </KeywordList>
      <CoiStatement>No conflicts of interest, financial or otherwise, are declared by the authors.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32412778</ArticleId>
        <ArticleId IdType="pmc">PMC7474442</ArticleId>
        <ArticleId IdType="doi">10.1152/ajpheart.00150.2020</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Aaker A, McCormack JG, Hirai T, Musch TI. 
Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction. J Cardiovasc Pharmacol
28: 353–362, 1996. doi:10.1097/00005344-199609000-00002. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00005344-199609000-00002</ArticleId>
            <ArticleId IdType="pubmed">8877580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armour JA.
Potential clinical relevance of the ‘little brain’ on the mammalian heart. Exp Physiol
93: 165–176, 2008. doi:10.1113/expphysiol.2007.041178. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/expphysiol.2007.041178</ArticleId>
            <ArticleId IdType="pubmed">17981929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beaumont E, Salavatian S, Southerland EM, Vinet A, Jacquemet V, Armour JA, Ardell JL. 
Network interactions within the canine intrinsic cardiac nervous system: implications for reflex control of regional cardiac function. J Physiol
591: 4515–4533, 2013. doi:10.1113/jphysiol.2013.259382. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2013.259382</ArticleId>
            <ArticleId IdType="pmc">PMC3784196</ArticleId>
            <ArticleId IdType="pubmed">23818689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beaumont E, Southerland EM, Hardwick JC, Wright GL, Ryan S, Li Y, KenKnight BH, Armour JA, Ardell JL. 
Vagus nerve stimulation mitigates intrinsic cardiac neuronal and adverse myocyte remodeling postmyocardial infarction. Am J Physiol Heart Circ Physiol
309: H1198–H1206, 2015. doi:10.1152/ajpheart.00393.2015. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00393.2015</ArticleId>
            <ArticleId IdType="pmc">PMC4666924</ArticleId>
            <ArticleId IdType="pubmed">26276818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O’Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee . 
Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association. Circulation
139: e56–e528, 2019. doi:10.1161/CIR.0000000000000659. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIR.0000000000000659</ArticleId>
            <ArticleId IdType="pubmed">30700139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bibevski S, Dunlap ME. 
Ganglionic mechanisms contribute to diminished vagal control in heart failure. Circulation
99: 2958–2963, 1999. doi:10.1161/01.CIR.99.22.2958. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.99.22.2958</ArticleId>
            <ArticleId IdType="pubmed">10359742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bibevski S, Dunlap ME. 
Prevention of diminished parasympathetic control of the heart in experimental heart failure. Am J Physiol Heart Circ Physiol
287: H1780–H1785, 2004. doi:10.1152/ajpheart.00430.2004. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00430.2004</ArticleId>
            <ArticleId IdType="pubmed">15191889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brack KE, Winter J, Ng GA. 
Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation–tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure. Heart Fail Rev
18: 389–408, 2013. doi:10.1007/s10741-012-9314-2. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10741-012-9314-2</ArticleId>
            <ArticleId IdType="pmc">PMC3677978</ArticleId>
            <ArticleId IdType="pubmed">22678767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buckley U, Shivkumar K, Ardell JL. 
Autonomic Regulation Therapy in Heart Failure. Curr Heart Fail Rep
12: 284–293, 2015. doi:10.1007/s11897-015-0263-7. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11897-015-0263-7</ArticleId>
            <ArticleId IdType="pmc">PMC4607027</ArticleId>
            <ArticleId IdType="pubmed">26054327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cahalin LP, Arena R, Labate V, Bandera F, Lavie CJ, Guazzi M. 
Heart rate recovery after the 6 min walk test rather than distance ambulated is a powerful prognostic indicator in heart failure with reduced and preserved ejection fraction: a comparison with cardiopulmonary exercise testing. Eur J Heart Fail
15: 519–527, 2013. doi:10.1093/eurjhf/hfs216. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurjhf/hfs216</ArticleId>
            <ArticleId IdType="pubmed">23397578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cauley E, Wang X, Dyavanapalli J, Sun K, Garrott K, Kuzmiak-Glancy S, Kay MW, Mendelowitz D. 
Neurotransmission to parasympathetic cardiac vagal neurons in the brain stem is altered with left ventricular hypertrophy-induced heart failure. Am J Physiol Heart Circ Physiol
309: H1281–H1287, 2015. doi:10.1152/ajpheart.00445.2015. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00445.2015</ArticleId>
            <ArticleId IdType="pmc">PMC4631536</ArticleId>
            <ArticleId IdType="pubmed">26371169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Champion HC, Skaf MW, Hare JM. 
Role of nitric oxide in the pathophysiology of heart failure. Heart Fail Rev
8: 35–46, 2003. doi:10.1023/A:1022142904202. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1022142904202</ArticleId>
            <ArticleId IdType="pubmed">12652158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. 
Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med
341: 1351–1357, 1999. doi:10.1056/NEJM199910283411804. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199910283411804</ArticleId>
            <ArticleId IdType="pubmed">10536127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dyavanapalli J, Rimmer K, Harper AA. 
The action of high K+ and aglycaemia on the electrical properties and synaptic transmission in rat intracardiac ganglion neurones in vitro. Exp Physiol
94: 201–212, 2009. doi:10.1113/expphysiol.2008.044784. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/expphysiol.2008.044784</ArticleId>
            <ArticleId IdType="pmc">PMC2713859</ArticleId>
            <ArticleId IdType="pubmed">18978036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dyavanapalli J, Rimmer K, Harper AA. 
Reactive oxygen species alters the electrophysiological properties and raises [Ca2+]i in intracardiac ganglion neurons. Am J Physiol Regul Integr Comp Physiol
299: R42–R54, 2010. doi:10.1152/ajpregu.00053.2010. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.00053.2010</ArticleId>
            <ArticleId IdType="pmc">PMC2917765</ArticleId>
            <ArticleId IdType="pubmed">20445155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Floras JS.
Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand
177: 391–398, 2003. doi:10.1046/j.1365-201X.2003.01087.x. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-201X.2003.01087.x</ArticleId>
            <ArticleId IdType="pubmed">12609011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Florea VG, Cohn JN. 
The autonomic nervous system and heart failure. Circ Res
114: 1815–1826, 2014. doi:10.1161/CIRCRESAHA.114.302589. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.114.302589</ArticleId>
            <ArticleId IdType="pubmed">24855204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garrott K, Dyavanapalli J, Cauley E, Dwyer MK, Kuzmiak-Glancy S, Wang X, Mendelowitz D, Kay MW. 
Chronic activation of hypothalamic oxytocin neurons improves cardiac function during left ventricular hypertrophy-induced heart failure. Cardiovasc Res
113: 1318–1328, 2017. doi:10.1093/cvr/cvx084. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cvr/cvx084</ArticleId>
            <ArticleId IdType="pmc">PMC5852539</ArticleId>
            <ArticleId IdType="pubmed">28472396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He B, Lu Z, He W, Wu L, Huang B, Yu L, Cui B, Hu X, Jiang H. 
Effects of low-intensity atrial ganglionated plexi stimulation on ventricular electrophysiology and arrhythmogenesis. Auton Neurosci
174: 54–60, 2013. doi:10.1016/j.autneu.2013.01.004. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autneu.2013.01.004</ArticleId>
            <ArticleId IdType="pubmed">23375649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He B, Lu Z, Jiang H. 
Atrial ganglionated plexi stimulation may be an effective therapeutic tool for the treatment of heart failure. Med Hypotheses
81: 905–907, 2013. doi:10.1016/j.mehy.2013.08.008. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mehy.2013.08.008</ArticleId>
            <ArticleId IdType="pubmed">24018286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henning RJ, Sawmiller DR. 
Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc Res
49: 27–37, 2001. doi:10.1016/S0008-6363(00)00229-7. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0008-6363(00)00229-7</ArticleId>
            <ArticleId IdType="pubmed">11121793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoover DB, Isaacs ER, Jacques F, Hoard JL, Pagé P, Armour JA. 
Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia. Neuroscience
164: 1170–1179, 2009. doi:10.1016/j.neuroscience.2009.09.001. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2009.09.001</ArticleId>
            <ArticleId IdType="pubmed">19747529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horackova M, Armour JA. 
Role of peripheral autonomic neurones in maintaining adequate cardiac function. Cardiovasc Res
30: 326–335, 1995. doi:10.1016/0008-6363(95)00105-0. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0008-6363(95)00105-0</ArticleId>
            <ArticleId IdType="pubmed">7585822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klein HU, Ferrari GM. 
Vagus nerve stimulation: A new approach to reduce heart failure. Cardiol J
17: 638–644, 2010. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21154273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovach JA, Gottdiener JS, Verrier RL. 
Vagal modulation of epicardial coronary artery size in dogs. A two-dimensional intravascular ultrasound study. Circulation
92: 2291–2298, 1995. doi:10.1161/01.CIR.92.8.2291. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.92.8.2291</ArticleId>
            <ArticleId IdType="pubmed">7554214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krashes MJ, Koda S, Ye C, Rogan SC, Adams AC, Cusher DS, Maratos-Flier E, Roth BL, Lowell BB. 
Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest
121: 1424–1428, 2011. doi:10.1172/JCI46229. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI46229</ArticleId>
            <ArticleId IdType="pmc">PMC3069789</ArticleId>
            <ArticleId IdType="pubmed">21364278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy MN.
Sympathetic-parasympathetic interactions in the heart. Circ Res
29: 437–445, 1971. doi:10.1161/01.RES.29.5.437. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.RES.29.5.437</ArticleId>
            <ArticleId IdType="pubmed">4330524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. 
Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation
109: 120–124, 2004. doi:10.1161/01.CIR.0000105721.71640.DA. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.0000105721.71640.DA</ArticleId>
            <ArticleId IdType="pubmed">14662714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez PF, Okoshi K, Zornoff LA, Oliveira SA Jr, Campos DH, Lima AR, Damatto RL, Cezar MD, Bonomo C, Guizoni DM, Padovani CR, Cicogna AC, Okoshi MP. 
Echocardiographic detection of congestive heart failure in postinfarction rats. J Appl Physiol (1985)
111: 543–551, 2011. doi:10.1152/japplphysiol.01154.2010. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/japplphysiol.01154.2010</ArticleId>
            <ArticleId IdType="pubmed">21617080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLean IW, Nakane PK. 
Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem
22: 1077–1083, 1974. doi:10.1177/22.12.1077. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/22.12.1077</ArticleId>
            <ArticleId IdType="pubmed">4374474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsson KR Jr, Duscha BD, Hranitzky PM, Kraus WE. 
Chronic heart failure and exercise intolerance: the hemodynamic paradox. Curr Cardiol Rev
4: 92–100, 2008. doi:10.2174/157340308784245757. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/157340308784245757</ArticleId>
            <ArticleId IdType="pmc">PMC2779357</ArticleId>
            <ArticleId IdType="pubmed">19936283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA. 
Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation
98: 1510–1516, 1998. doi:10.1161/01.CIR.98.15.1510. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.98.15.1510</ArticleId>
            <ArticleId IdType="pubmed">9769304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pickard JM, Burke N, Davidson SM, Yellon DM. 
Intrinsic cardiac ganglia and acetylcholine are important in the mechanism of ischaemic preconditioning. Basic Res Cardiol
112: 11, 2017. doi:10.1007/s00395-017-0601-x. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00395-017-0601-x</ArticleId>
            <ArticleId IdType="pmc">PMC5236079</ArticleId>
            <ArticleId IdType="pubmed">28091727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I, DiCarlo LA, Ardell JL, Rector TS, Amurthur B, KenKnight BH, Anand IS. 
Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. J Card Fail
20: 808–816, 2014. doi:10.1016/j.cardfail.2014.08.009. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cardfail.2014.08.009</ArticleId>
            <ArticleId IdType="pubmed">25187002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reid JV, Ito BR, Huang AH, Buffington CW, Feigl EO. 
Parasympathetic control of transmural coronary blood flow in dogs. Am J Physiol
249: H337–H343, 1985. doi:10.1152/ajpheart.1985.249.2.H337. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.1985.249.2.H337</ArticleId>
            <ArticleId IdType="pubmed">2992294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rogan SC, Roth BL. 
Remote control of neuronal signaling. Pharmacol Rev
63: 291–315, 2011. doi:10.1124/pr.110.003020. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/pr.110.003020</ArticleId>
            <ArticleId IdType="pmc">PMC3082452</ArticleId>
            <ArticleId IdType="pubmed">21415127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rouleau JR, Simard D, Rodrigue N, Blouin A, Kingma JG Jr. 
Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition. Auton Neurosci
97: 12–18, 2002. doi:10.1016/S1566-0702(02)00002-4. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1566-0702(02)00002-4</ArticleId>
            <ArticleId IdType="pubmed">12036181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasaki K, Suzuki M, Mieda M, Tsujino N, Roth B, Sakurai T. 
Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice. PLoS One
6: e20360, 2011. doi:10.1371/journal.pone.0020360. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0020360</ArticleId>
            <ArticleId IdType="pmc">PMC3103553</ArticleId>
            <ArticleId IdType="pubmed">21647372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scherlag BJ, Po S. 
The intrinsic cardiac nervous system and atrial fibrillation. Curr Opin Cardiol
21: 51–54, 2006. doi:10.1097/01.hco.0000198980.40390.e4. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.hco.0000198980.40390.e4</ArticleId>
            <ArticleId IdType="pubmed">16355030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sjaastad I, Sejersted OM, Ilebekk A, Bjornerheim R. 
Echocardiographic criteria for detection of postinfarction congestive heart failure in rats. J Appl Physiol (1985)
89: 1445–1454, 2000. doi:10.1152/jappl.2000.89.4.1445. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/jappl.2000.89.4.1445</ArticleId>
            <ArticleId IdType="pubmed">11007581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tu H, Liu J, Zhang D, Zheng H, Patel KP, Cornish KG, Wang WZ, Muelleman RL, Li YL. 
Heart failure-induced changes of voltage-gated Ca2+ channels and cell excitability in rat cardiac postganglionic neurons. Am J Physiol Cell Physiol
306: C132–C142, 2014. doi:10.1152/ajpcell.00223.2013. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00223.2013</ArticleId>
            <ArticleId IdType="pmc">PMC3919990</ArticleId>
            <ArticleId IdType="pubmed">24025863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van de Vegte YJ, van der Harst P, Verweij N. 
Heart rate recovery 10 seconds after cessation of exercise predicts death. J Am Heart Assoc
7: e008341, 2018. doi:10.1161/JAHA.117.008341. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.117.008341</ArticleId>
            <ArticleId IdType="pmc">PMC6015434</ArticleId>
            <ArticleId IdType="pubmed">29622586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Li H, Yu L, Chen M, Wang Z, Huang B, Zhou L, Zhou X, Jiang H. 
Anti-arrhythmic effects of atrial ganglionated plexi stimulation is accompanied by preservation of connexin43 protein in ischemia-reperfusion canine model. Int J Clin Exp Med
8: 22098–22107, 2015. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4729970</ArticleId>
            <ArticleId IdType="pubmed">26885184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang T, Miller KE. 
Characterization of glutamatergic neurons in the rat atrial intrinsic cardiac ganglia that project to the cardiac ventricular wall. Neuroscience
329: 134–150, 2016. doi:10.1016/j.neuroscience.2016.05.002. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2016.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC5922425</ArticleId>
            <ArticleId IdType="pubmed">27167082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu SJ, Li YC, Shi ZW, Lin ZH, Rao ZH, Tai SC, Chu MP, Li L, Lin JF. 
Alteration of Cholinergic Anti-Inflammatory Pathway in Rat With Ischemic Cardiomyopathy-Modified Electrophysiological Function of Heart. J Am Heart Assoc
6: 6, 2017. doi:10.1161/JAHA.117.006510. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.117.006510</ArticleId>
            <ArticleId IdType="pmc">PMC5634297</ArticleId>
            <ArticleId IdType="pubmed">28928157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi F, Kawana K, Tanonaka K, Kamano I, Igarashi T, Gen E, Fujimoto Y, Maki T, Sanbe A, Nasa Y, Takeo S. 
Improvement of exercise capacity of rats with chronic heart failure by long-term treatment with trandolapril. Br J Pharmacol
126: 1585–1592, 1999. doi:10.1038/sj.bjp.0702471. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjp.0702471</ArticleId>
            <ArticleId IdType="pmc">PMC1565941</ArticleId>
            <ArticleId IdType="pubmed">10323590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshinari K, Yaoita H, Maehara K, Maruyama Y. 
Different therapeutic responses to treadmill exercise of heart failure due to ischemia and infarction in rats. Cardiovasc Res
65: 457–468, 2005. doi:10.1016/j.cardiores.2004.10.039. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cardiores.2004.10.039</ArticleId>
            <ArticleId IdType="pubmed">15639485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan BX, Ardell JL, Hopkins DA, Armour JA. 
Differential cardiac responses induced by nicotine sensitive canine atrial and ventricular neurones. Cardiovasc Res
27: 760–769, 1993. doi:10.1093/cvr/27.5.760. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cvr/27.5.760</ArticleId>
            <ArticleId IdType="pubmed">8348576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zannad F, De Ferrari GM, Tuinenburg AE, Wright D, Brugada J, Butter C, Klein H, Stolen C, Meyer S, Stein KM, Ramuzat A, Schubert B, Daum D, Neuzil P, Botman C, Castel MA, D’Onofrio A, Solomon SD, Wold N, Ruble SB. 
Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J
36: 425–433, 2015. doi:10.1093/eurheartj/ehu345. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehu345</ArticleId>
            <ArticleId IdType="pmc">PMC4328197</ArticleId>
            <ArticleId IdType="pubmed">25176942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao G, Shen W, Xu X, Ochoa M, Bernstein R, Hintze TH. 
Selective impairment of vagally mediated, nitric oxide-dependent coronary vasodilation in conscious dogs after pacing-induced heart failure. Circulation
91: 2655–2663, 1995. doi:10.1161/01.CIR.91.10.2655. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.91.10.2655</ArticleId>
            <ArticleId IdType="pubmed">7743629</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
